A COMPARITIVE STUDY TO EVALUVATE THE EFFICACY OF AMLODIPINE WITH BISOPROLOL IN HYPERTENSIVE PATIENTS
Aim and Objectives: The main aim of this study is to evaluate the efficacy of amlodipine and bisoprolol in hypertensive patients and to find out the
decreased level of blood pressure (BP)(systolic/diastolic) using amlodipine compared with bisoprolol in hypertensive patients.
Materials and Methods: This study which includes spontaneous prospective monitoring of hypertensive patients undergoing different types of
antiâ€‘hypertensive treatments were carried out for a period of 6 months by us on both in-patient, as well as out-patients.
Result and Discussion: A total of 76 patients were screened. At the beginning of our study, 1st month reading was taken as the initial value and
6th month value was taken as the final value. Pre-treatment baseline of systolic BP was 154.7Â±6.1 mmHg and 156Â±6.7 mmHg in Group I and Group II
respectively. Patients receiving amlodipine had mean (Â±SD) reduction in systolic BP from baseline of 16.7Â±7.9 mmHg, whereas patients are receiving
bisoprolol had a reduction from baseline of 19Â±5.5 mmHg representing respective decrease of 10.8% and 12%. Treatment with both amlodipine and
bisoprolol therapy resulted in a significantly greater reduction in systolic BP.
Conclusion: The percentage reduction of systolic, as well as diastolic in the hypertensive patient, was more in bisoprolol treated group than
amlodipine treated. So which suggest that the bisoprolol is having a very good control over systolic and diastolic BP level and simultaneously it is
more beneficial for the treatment of hypertension.
Keywords: Amlodipine, Bisoprolol, Anti-hypertensives.
therapy. Use of fixed-dose combination therapy. Arch Intern Med
2. Dighore PN, Patil PH, Kuchake VG, Maheswari OD. Prescription
pattern of Antihypertensive Drugs. Indian J Hosp Pharm 2009;46:78â€‘82.
3. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective
Studies Collaboration. Age-specific relevance of usual blood pressure
to vascular mortality: A meta-analysis of individual data for one million
adults in 61 prospective studies. Lancet 2002;360(9349):1903-13.
4. Liu PH, Wang JD. Antihypertensive medication prescription patterns
and time trends for newly-diagnosed uncomplicated hypertension
patients in Taiwan. BMC Health Serv Res 2008;8:133.
5. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment,
and control of hypertension in the United States, 1988-2000. JAMA
6. Tiwari H, Kumar A, Kulkarni SK. Prescription monitoring of antihypertensive
drug utilisation at the Panjab University Health Centre in
India. Singapore Med J 2004;45:117-20.
7. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA,
Izzo JL Jr, et al. Seventh report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment of High Blood
Pressure. Hypertension 2003;42(6):1206-52.
8. Warnock DG. Genetic forms of human hypertension. Curr Opin
Nephrol Hypertens 2001;10(4):493-9.
9. Staessen JA, Wang J, Bianchi G, BirkenhÃ¤ger WH. Essential
hypertension. Lancet 2003;361:1629-41.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.